Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Treasury Shares (2021 - 2025)

PAVmed has reported Treasury Shares over the past 1 years, most recently at $408000.0 for Q4 2022.

  • Quarterly results put Treasury Shares at $67739.0 for Q4 2025, up 526.57% from a year ago — trailing twelve months through Dec 2025 was $67739.0 (up 526.57% YoY), and the annual figure for FY2025 was $67739.0, up 526.57%.
  • Treasury Shares for Q4 2025 was $67739.0 at PAVmed, down from $2.0 million in the prior quarter.
  • Over the last five years, Treasury Shares for PAVM hit a ceiling of $3.9 million in Q2 2024 and a floor of $10811.0 in Q4 2024.
  • Median Treasury Shares over the past 5 years was $975000.0 (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Treasury Shares: soared 1782.31% in 2022 and later plummeted 99.54% in 2024.
  • PAVmed's Treasury Shares stood at $111109.0 in 2021, then soared by 1782.31% to $2.1 million in 2022, then increased by 11.76% to $2.3 million in 2023, then tumbled by 99.54% to $10811.0 in 2024, then skyrocketed by 526.57% to $67739.0 in 2025.
  • The last three reported values for Treasury Shares were $408000.0 (Q4 2022), $408000.0 (Q3 2022), and $548000.0 (Q2 2022) per Business Quant data.